視聴可能期間外です。
The 39th Sapporo International Cancer Symposium

P-1 Refractoriness to cancer cell reprogramming unveils cancer type-specific therapeutic targets

このポスターに関するお問い合わせ先

The 39th Sapporo International Cancer Symposium Meeting Office

Japanese Foundation For Cancer Research

3-8-31 Ariake Koto-ku Tokyo 135-8550, Japan

E-mail: sics39@jfcr.or.jp

Kohei Nagata

Division of Stem Cell Pathology, Institute of Medical Science, University of Tokyo

略歴

2013: graduate University of Toyama

2019-present:  Division of Stem Cell Pathology, Center for Experimental Medicine and Systems Biology, Institute of Medical Science, University of Tokyo

0.11995410919189 秒